Neuroplasticity predicts outcome of optic neuritis independent of tissue damage

Annals of Neurology

Volumn 67, Issue 1, 2010, Pages 99-113

  Jenkins, Thomas M ^a   Toosy, Ahmed T ^a   Ciccarelli, Olga ^a   Miszkiel, Katherine A ^a   Wheeler Kingshott, Claudia A ^a   Henderson, Andrew P ^a   Kallis, Constantinos ^a,c   Mancini, Laura ^a   Plant, Gordon T ^b,d   Miller, David H ^a,b   Thompson, Alan J ^a,b  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b NATIONAL HOSPITAL FOR NEUROLOGY AND NEUROSURGERY   (United Kingdom)

^c LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^d MOORFIELDS EYE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DEMYELINATION; ELECTROPHYSIOLOGY; EVOKED VISUAL RESPONSE; FEMALE; FUNCTIONAL MAGNETIC RESONANCE IMAGING; HUMAN; INFLAMMATION; MALE; NERVE CELL PLASTICITY; OCCIPITAL CORTEX; OPTIC NEURITIS; OPTICAL COHERENCE TOMOGRAPHY; PRIORITY JOURNAL; PROGNOSIS; REMYELINIZATION; TISSUE INJURY; VISION; VISUAL ACUITY; VISUAL SYSTEM;

ADULT; AXONS; BRAIN; DEMYELINATING DISEASES; EVOKED POTENTIALS, VISUAL; FEMALE; FOLLOW-UP STUDIES; HUMANS; LONGITUDINAL STUDIES; MAGNETIC RESONANCE IMAGING; MALE; NEURONAL PLASTICITY; OPTIC NERVE; OPTIC NEURITIS; PROGNOSIS; TIME FACTORS; TOMOGRAPHY, OPTICAL COHERENCE; VISION DISORDERS; VISUAL PATHWAYS; YOUNG ADULT;

EID: 77649283580     PISSN: 03645134     EISSN: 15318249     Source Type: Journal    
DOI: 10.1002/ana.21823     Document Type: Article

References (50)

1. Beck RW, Gal RL, Bhatti MT, et al. Visual function more than 10 years after optic neuritis: experience of the optic neuritis treatment trial. Am J Ophthalmol 2004;137:77-83.
2. Cleary PA, Beck RW, Bourque LB, et al. Visual symptoms after optic neuritis. Results from the Optic Neuritis Treatment Trial. J Neuroophthalmol 1997;17:18-23.
3. Kolappan M, Connick P, Compston A, et al. Optic neuritis as a sentinel lesion to study neuroprotection and repair in a trial of autologous mesenchymal stem cells in multiple sclerosis (Abstract). Mult Scler 2008;14:S1:284.
4. Smith KJ, McDonald WI. The pathophysiology of multiple sclerosis: the mechanisms underlying the production of symptoms and the natural history of the disease. Philos Trans R Soc Lond B Biol Sci 1999;354:1649-1673.
5. Jones SJ. Visual evoked potentials after optic neuritis. Effect of time interval, age and disease dissemination. J Neurol 1993;240:489-494.
6. Hickman SJ, Toosy AT, Jones SJ, et al. Serial magnetization transfer imaging in acute optic neuritis. Brain 2004;127:692-700.
7. Inglese M, Ghezzi A, Bianchi S, et al. Irreversible disability and tissue loss in multiple sclerosis: a conventional and magnetization transfer magnetic resonance imaging study of the optic nerves. Arch Neurol 2002;59:250-255.
8. Hickman SJ, Toosy AT, Jones SJ, et al. A serial MRI study following optic nerve mean area in acute optic neuritis. Brain 2004;127:2498-2505.
9. Miller DH, Barkhof F, Frank JA, et al. Measurement of atrophy in multiple sclerosis: pathological basis, methodological aspects and clinical relevance. Brain 2002;125:1676-1695.
10. Toosy AT, Hickman SJ, Miszkiel KA, et al. Adaptive cortical plasticity in higher visual areas after acute optic neuritis. Ann Neurol 2005;57:622-633.
11. Levin N, Orlov T, Dotan S, et al. Normal and abnormal fMRI activation patterns in the visual cortex after recovery from optic neuritis. Neuroimage 2006;33:1161-1168.
12. Korsholm K, Madsen KH, Frederiksen JL, et al. Recovery from optic neuritis: an ROI-based analysis of LGN and visual cortical areas. Brain 2007;130:1244-1253.
13. Kolappan M, Henderson A, Jenkins T, et al. Assessing structure and function of the afferent visual pathway in multiple sclerosis and associated optic neuritis. J Neurol 2009;256:305-319.
14. Hickman SJ, Toosy AT, Miszkiel KA, et al. Visual recovery following acute optic neuritis-a clinical, electrophysiological and magnetic resonance imaging study. J Neurol 2004;251:996-1005.
15. Kupersmith MJ, Alban T, Zeiffer B, et al. Contrast-enhanced MRI in acute optic neuritis: relationship to visual performance. Brain 2002;125:812-822.
16. Kupersmith MJ, Gal RL, Beck RW, et al. Visual function at baseline and 1 month in acute optic neuritis: predictors of visual outcome. Neurology 2007;69:508-514.
17. Trip SA, Schlottmann PG, Jones SJ, et al. Retinal nerve fiber layer axonal loss and visual dysfunction in optic neuritis. Ann Neurol 2005;58:383-391.
18. Costello F, Coupland S, Hodge W, et al. Quantifying axonal loss after optic neuritis with optical coherence tomography. Ann Neurol 2006;59:963-969.
19. Hickman SJ, Brierley CM, Brex PA, et al. Continuing optic nerve atrophy following optic neuritis: a serial MRI study. Mult Scler 2002;8:339-342.
20. Ferris FL, III, Kassoff A, Bresnick GH, et al. New visual acuity charts for clinical research. Am J Ophthalmol 1982;94:91-96.
21. Brusa A, Jones SJ, Plant GT. Long-term remyelination after optic neuritis: A 2-year visual evoked potential and psychophysical serial study. Brain 2001;124:468-479.
22. Henderson AP, Trip SA, Schlottmann PG, et al. An investigation of the retinal nerve fibre layer in progressive multiple sclerosis using optical coherence tomography. Brain 2008;131:277-287.
23. Hickman SJ, Brex PA, Brierley CM, et al. Detection of optic nerve atrophy following a single episode of unilateral optic neuritis by MRI using a fat-saturated short-echo fast FLAIR sequence. Neuroradiology 2001;43:123-128.
24. Plummer DL. DispImage: a display and analysis tool for medical images. Riv Neuroradiol 1992;5:489-495.
25. Cook PA, Symms M, Boulby PA, et al. Optimal acquisition orders of diffusion-weighted MRI measurements. J Magn Reson Imaging 2007;25:1051-1058.
26. Behrens TE, Woolrich MW, Jenkinson M, et al. Characterization and propagation of uncertainty in diffusion-weighted MR imaging. Magn Reson Med 2003;50:1077-1088.
27. Behrens TE, Johansen-Berg H, Woolrich MW, et al. Non-invasive mapping of connections between human thalamus and cortex using diffusion imaging. Nat Neurosci 2003;6:750-757.
28. Dale AM, Fischl B, Sereno MI. Cortical surface-based analysis. I. Segmentation and surface reconstruction. Neuroimage 1999;9:179-194.
29. Fischl B, Sereno MI, Dale AM. Cortical surface-based analysis. II: Inflation, flattening, and a surface-based coordinate system. Neuroimage 1999;9:195-207.
30. Fischl B, Dale AM. Measuring the thickness of the human cerebral cortex from magnetic resonance images. Proc Natl Acad Sci USA 2000;97:11050-11055.
31. Fischl B, van der KA, Destrieux C, et al. Automatically parcellating the human cerebral cortex. Cereb Cortex 2004;14:11-22.
32. Jenkins TM, Mancini L, Toosy AT, et al. A quadrant-specific monocular visual functional MRI paradigm designed to minimize attention and loss-of-fixation biases (Abstract). ISMRM 16th Scientific Meeting and Exhibition, Toronto, Ontario, Canada. 2008;2460.
33. Brett M, Anton, JL, Valabregue R, et al. Region-of-interest analysis using an SPM toolbox (Abstract). 8th International Conference on Functional Mapping of the Human Brain, Sendai, Japan. Neuroimage 2002;2:16.
34. Alamouti B, Funk J. Retinal thickness decreases with age: an OCT study. Br J Ophthalmol 2003;87:899-901.
35. Holm S. A simple sequentially rejective multiple test procedure. Scand J Stat 1979;6:65-70.
36. Aickin M, Gensler H. Adjusting for multiple testing when reporting research results: the Bonferroni vs Holm methods. Am J Public Health 1996;86:726-728.
37. Quigley HA, Davis EB, Anderson DR. Descending optic nerve degeneration in primates. Invest Ophthalmol Vis Sci 1977;16:841-849.
38. Klistorner A, Arvind H, Nguyen T, et al. Axonal loss and myelin in early ON loss in postacute optic neuritis. Ann Neurol 2008;64:325-331.
39. Johansen-Berg H. Structural plasticity: rewiring the brain. Curr Biol 2007;17:141-144.
40. Perneger TV. What's wrong with Bonferroni adjustments. BMJ 1998;316:1236-1238.
41. Rothman KJ. No adjustments are needed for multiple comparisons. Epidemiology 1990;1:43-46.
42. Guye M, Parker GJ, Symms M, et al. Combined functional MRI and tractography to demonstrate the connectivity of the human primary motor cortex in vivo. Neuroimage 2003;19:1349-1360.
43. Horton JC, Landau K, Maeder P, et al. Magnetic resonance imaging of the human lateral geniculate body. Arch Neurol 1990;47:1201-1206.
44. Ciccarelli O, Behrens TE, Altmann DR, et al. Probabilistic diffusion tractography: a potential tool to assess the rate of disease progression in amyotrophic lateral sclerosis. Brain 2006;129:1859-1871.
45. Jenkinson M, Smith S. A global optimisation method for robust affine registration of brain images. Med Image Anal 2001;5:143-156.
46. Zhang Y, Brady M, Smith S. Segmentation of brain MR images through a hidden Markov random field model and the expectationmaximization algorithm. IEEE Trans Med Imaging 2001;20:45-57.
47. Thottakara P, Lazar M, Johnson SC, et al. Application of Brodmann's area templates for ROI selection in white matter tractography studies. Neuroimage 2006;29:868-878.
48. Ciccarelli O, Wheeler-Kingshott CA, McLean MA, et al. Spinal cord spectroscopy and diffusion-based tractography to assess acute disability in multiple sclerosis. Brain 2007;130:2220-2231.
49. Slotnick SD, Klein SA, Carney T, et al. Electrophysiological estimate of human cortical magnification. Clin Neurophysiol 2001;112:1349-1356.
50. Jenkins TM, Mancini L, Ciccarelli O, et al. Using structural and functional magnetic resonance imaging to explain visual loss at the onset of acute optic neuritis (Abstract). Mult Scler 2008;14;S1:276.